Académique Documents
Professionnel Documents
Culture Documents
Spectrum of Diseas&
Elliot K Fishman, MD
JanetE. Kuhlman, MD
Ricbardj Jones, MD
U INTRODUCTION
Computed tomography (CT) has many roles in the evaluation of Hodgkin or non-
Hodgkin lymphoma. It is used to (a) define the full extent of disease to allow accu-
rate staging, (b) assist in treatment planning (ie, determine the site of nodal biopsy,
create radiation therapy portals, and select the chemotherapy protocol), (C) evaluate
the response to therapy, and (d) monitor patient progress and possible relapse. Nu-
merous articles over the past decade have quantified the value of CT in cases of lym-
phoma (1-14).
In a review of 203 patients with newly diagnosed Hodgkin disease, Castellino et
al (13) found that CT ofthe chest resulted in a change in treatment in 9.4% of pa-
tients (19 of 203), including 13.8% (nine of 65) of those undergoing radiation ther-
apy and 8.2% (10 of 122) of those undergoing combined modality treatment.
Khoury et al (15), in comparing CT and chest radiography in a series of 48 patients
with non-Hodgkin lymphoma, found that chest CT affected management in eight of
25 treated and five of 19 untreated patients.
CT of the abdomen and pelvis has also been shown to be of great value in the
staging and follow-up oflymphoma. Neumann et al (16) reviewed their experience
and found that in cases of non-Hodgkin lymphoma, CT performed at the time of
presentation resulted in upgrading of the clinical stage in 33% of patients; in addi-
tion, CT enabled detection of unsuspected active disease in 43% of patients thought
to be in remission. Clinically important upstaging was the result in 15% ofall exami-
nations.
From the Russell H. Morgan Department of Radiology and Radiological Science (E.K.F., J.E.K.) and the Department of
Oncology (R.J.J.), TheJohns Hopkins Medical Institutions, 600 N Wolfe St. Baltimore, MD 21205. From the 1990 RSNA
annual meeting. Received December 26, 1990; revision requested February 8, 1991, and received February 26; accepted
February 26. Address reprint requests to E.K.F.
C RSNA, 1991
647
Table 1
Histologic Classification of Non-Hodgkin Lymphoma
Low grade
A. Small lymphocytic Well-differentiated lymphocytic
B. Follicular, predominantly small cleaved cell Nodular, poorly differentiated lymphocytic
C. Follicular, mixed small and large cell Nodular, mixed
Intermediate grade
D. Follicular, predominantly large cell Nodular, histiocytic
E. Diffuse, small cleaved cell Diffuse, poorly differentiated lymphocytic
F. Diffuse, mixed small and large cell Diffuse, mixed
G. Diffuse, large cell, cleaved or noncleaved
High grade
H. Diffused large cell, immunoblastic
I. Small, noncleaved cell
J. Lymphoblastic Undifferentiated
This article presents a systematic review of Hodgkin lymphoma (2). Although there are
the common and uncommon appearances of minor differences in the clinical presentation
lymphoma in the chest and abdomen. Poten- and course for the subtypes of non-Hodgkin
tial pitfalls and limitations of CT in staging lymphoma within each of the three categories
and follow-up are also addressed. Although an listed, the lymphomas within each category
in-depth discussion of the treatment of lym- can generally be approached similarly. In ad-
phoma is beyond the scope of this article, it is dition, follicular large cell and diffuse small
important to understand the therapeutic deci- cleaved cell lymphoma (grades D and E ) can
sions that are based on accurate CT staging, probably be regarded as low-grade lympho-
including the choice of chemotherapy, radia- mas, while diffuse, mixed small and large cell
tion therapy, or a combination of these mo- and diffuse large cell lymphomas (grades F
dalities. and G) can be approached as high-grade lym-
phomas. High-grade lymphomas are aggres-
U STAGING AND THERAPEUTIC sive, fast-growing malignancies that are rap-
CHOICES idly fatal if not treated; however, of about half
The treatment oflymphoma (both Hodgkin the patients can be cured with current treat-
and non-Hodgkin) is now effective, with a ment. Conversely, low-grade lymphomas are
substantial fraction of patients being cured. slow-growing diseases, and patients have long
However, the prognosis and type of therapy survivals (median, about 7 years) even if un-
are dictated by the histologic type and stage treated. Interestingly, however, with the ex-
ofdisease (1-7). Although the histopathologic ception oflocalized disease, low-grade lym-
subtype of Hodgkin disease correlates with phomas are incurable.
the stage of disease, it does not correlate with Adequate staging is critical
for determining
prognosis if stage is taken into account (1). the correct treatment Hodgkin of both
and
Conversely, the histologic subtype of non- non-Hodgkin lymphoma. Radiation therapy
Hodgkin lymphoma strongly affects prognosis has been the standard treatment for all early-
and treatment strategies. stage lymphomas, with cure rates ranging
The current universally accepted Interna- from about 50% for both low-grade (3) and
tional Working Formulation and the Rappa- high-grade (4) non-Hodgkin lymphomas to
port equivalent for histologic classification of over 80% for Hodgkin disease (5). Stage Ill-N
non-Hodgkin lymphoma are shown in Table Hodgkin disease and high-grade non-Hodgkin
1 . Table 2 shows the staging system for lymphoma require intensive combination che-
motherapy, with cure rates of about 50%
(6,7). Bulky early-stage disease also requires
chemotherapy for cure.
patients with abdominal lymphoma (a series nodes in patients with lymphoma are second-
of 125 patients); all responded favorably to ary to prior therapy (Figs 5, 6) (18-21). Calci-
therapy. The most common pathologic type of fled nodes are most commonly seen in the
lymphoma in cases of necrotic nodes is nodu- anterior mediastinum, especially in patients
lar sclerosing Hodgkin disease (Figs 1 2). , with Hodgkin disease who have undergone
Nodal necrosis following chemotherapy or radiation therapy. Histologic studies have
radiation therapy is not uncommon. We have shown these catcifications to be of the dystro-
recently noted several cases of nodal enhance- phic type. The significance of nodal calcifica-
ment following dynamic bolus injection of tion with regard to tumor viability and ulti-
iodinated contrast material (Figs 3, 4). In mate prognosis is still uncertain.
nearly all cases, the nodes were axillary. Al- The anterior mediastinal, pretracheal, and
though enhancing nodes are the hallmark of hilar nodal chains are the most common
Castleman disease, they can be seen in non- nodal chains involved by tymphoma in the
Hodgkin lymphoma. The ultimate significance chest. Careful attention to the axillary, para-
of nodal enhancement (if any) has not yet cardiac, and subcarinal nodal chains is impor-
been defined. tant in accurate staging. Two nodal chains
Although in rare cases calcifications may commonly overlooked are the superior dia-
occur within lymph nodes at the time of initial phragmatic and internal mammary lymph
presentation, most cases of calcified lymph node chains (10-12).
The superior diaphragmatic lymph nodes
or paracardiac nodes are located just above or
on the diaphragm and can be divided into
5a. 5b.
Figures 5, 6. (5) Large cell lymphoma in a 66-
year-old woman. (a) CT scan obtained before che-
motherapy shows extensive pancreaticoduodenal
nodes. (b) CT scan obtained after chemotherapy
shows that the nodes have decreased in size and
are partially calcified. (6) Hodgkin disease in a 79-
year-old woman in clinical remission for 8 years.
Patient had been treated with radiation delivered
to the mediastinum. CT scan demonstrates calcified
mediastinal nodes without recurrent tumor.
6.
9. 10.
Figures 7-10. (7)
Diffuse histiocytic lymphoma in a 28-year-old woman. CT scan shows small right para-
cardiac nodes. (8) Hodgkin disease in a 34-year-old woman. CT scan shows large left paracardiac nodes.
(9) Large cell lymphoma in a 79-year-old man. CT scan demonstrates bilaterally enlarged internal mammary
nodes. (10) Burkitt lymphoma in a 72-year-old woman. CT scan demonstrates large right internal mammary
nodes growing through the chest wall.
anterior, middle, and posterior groups. These 23.7% of nodes (nine of 38) in these patients
lymph nodes consist of nodes in the cardio- (Figs 7, 8).
phrenic angles, nodes in the most caudal por- Similarly, internal mammary adenopathy is
tion of the internal mammary chain, and difficult to detect at routine radiography (Figs
nodes along the pericardium. In a series of 9, 10). Scott and Fishman (22) noted that over
Castellino et al (13), the detection of cardio- 60% of cases of internal mammary adenopa-
phrenic angle nodes on CT scans of patients thy will be missed at routine radiography. In-
with Hodgkin disease resulted in modified ternal mammary adenopathy is usually seen in
treatment in 18.8% ofcases (three of 16). In patients with either lymphoma or breast can-
the same series, paracardiac nodes were de- cer. Ifoverlooked, these nodes can enlarge
tected on chest radiographs in only 12.5% and grow into or through the chest wall. Ster-
(two of 16) of the cases. In a review by Suss- nal involvement with either infiltration or de-
man et al (12), 40% of patients with enlarged struction can also occur.
paracardiac nodes had lymphoma. The nodes
associated with lymphoma tended to be bilat- . Lung Parenchyma
eral, multiple, greater than 2 cm in diameter, Involvement of the lung parenchyma at the
and lobulated or matted in appearance. time of initial diagnosis is more common in
Chest radiographs enabled detection of only Hodgkin disease than in non-Hodgkin dis-
ease. The lung parenchyma may be involved
at presentation in as many as 1 1 .6% of cases
14.
Figures 13-15. (13) Hodgkin disease in a 43-
year-old woman. CT scan shows enlarged left hilar
nodes with direct infiltration into the lung paren-
chyma. Small parenchymal nodules are also seen.
(14) Recurrent nodular sclerosing Hodgkin disease
in a 34-year-old woman. CT scan demonstrates ade-
nopathy in the right hilum, with tumor infiltrating
along lymphatic vessels into the lung parenchyma.
(15) Poorly differentiated lymphocytic lymphoma
in a 73-year-old woman. CT scan demonstrates a
large cavitary mass in the left upper lung.
c.--
15.
. --.,-..
ofHodgkin disease (23-25). In the patient diastinal or hilar adenopathy with direct ex-
with Hodgkin disease, lung involvement is tension along lymphatic vessels into the lung
often associated with mediastinal or hilar ade- parenchyma (Figs 13, 14). The third pattern is
nopathy. Primary lymphoma of the lung is peribronchial or perivascular lymphomatous
rare. deposits in a subsegmental or segmental dis-
The patterns of lymphomatous involvement tribution: These nodules and infiltration may
of the lung parenchyma are variable. One pat- at times be indistinguishable from pneumo-
tern consists of single or multiple nodules nia. Cavitary nodules may also be seen (Fig
similar to those seen in metastatic disease 1 5). Finally, a reticular infiltrative pattern in
(Figs 11 , 1 2). A second pattern consists of me- the lungs may be seen.
4- :
18c. 19.
Figures 18, 19. (18) Non-Hodgkin lymphoma in a 39-year-old man. (a) CT scan demonstrates multiple
nodules throughout the liver. CT scans obtained 3 months (b) and 6 months (c) after chemotherapy show
partial resolution of the tumor. (19) Diffuse small cell lymphoma in a 40-year-old man. CT scan of the liver
demonstrates diffuse infiltration of the liver by tumor.
from less than 1 cm to approximately 10 cm. 3. Diffuse hepatic involvement. The diffuse
Calcification is rare within these lesions un- infiltration of the liver by lymphoma is the
less the patient has undergone radiation ther- most difficult feature to detect on CT scans.
apy. Occasionally, these lesions can bleed, The lesions often have the same attenuation
and patients may present with an acute abdo- as hepatic parenchyma, or the appearance
men as a sign oftumor involvement (Fig 17). may be suggestive of fatty infiltration or pa-
2. Multifocal hepatic lesions. These can renchymal disease rather than tumor infiltra-
also be similar in appearance to metastatic tion (Fig 19).
disease or multifocal hepatoma. The lesions
vary in size but typically are 1-5 cm in diame-
ter (Fig 18).
21.
. Spleen
Splenic lymphoma can be classified as either
primary splenic lymphoma or lymphomatous The CT appearances and clinical presenta-
splenic involvement as part of more systemic tions (fever, left upper quadrant pain, mal-
disease (32). Primary splenic lymphoma is aise) of primary splenic lymphoma and
rare. When it does occur, it is usually a large splenic abscess can be similar (Figs 20, 21).
cell lymphoma. Non-Hodgkin lymphoma is This can be true with both Hodgkin and non-
the most common primary tumor of the Hodgkin lymphoma. One helpful point in the
spleen. In a series by Meyer et al (32), a large differential diagnosis is that splenic abscesses
solitary mass was the most common finding. rarely occur with lymphadenopathy.
At presentation, primary splenic lymphoma One of the weaknesses of any noninvasive
may be associated with disease in the splenic, imaging study has been the accurate detec-
hilar, or paraaortic nodal chains. tion of splenic involvement by lymphoma.
This weakness is partially due to the fact that
in most cases the disease either is infiltrative
or occurs as tumor foci well under a centime- They include (a) homogeneous enlargement
ter in diameter (32-34). Absolute measure- without a discrete mass, (b) solitary mass,
ments of splenic size are of limited value, with (c) multifocal lesions
(Figs 22, 23), and (d)
up to 30% ofenlarged spleens in lymphoma diffuse infiltration. appearance The at CT typi-
being free of tumor. Another study found a cally is one of diffuse areas of low attenuation
sensitivity of 38% and a specificity of 6 1% for or diffuse irregular splenic enhancement
detection of splenic lymphoma based on or- (Fig 24).
gan enlargement found at either physical or
imaging examination (33).
The CT appearances of splenic lymphoma
mirror the variety of pathologic appearances.
27.
2. Multiple masses. The multiple nodules This is especially true in patients with lym-
are usually bilateral and variable in size. The phomatous infiltration of the perirenal space.
nodules in one series were between 1 and 4.5 Renal function may be absent in these cases,
cm in diameter. The kidney is usually en- and the patients can have renal failure at pre-
larged but may occasionally be normal in size sentation (Figs 30-33).
(Fig 27). Depending on the specific CT appearance,
3. Infiltration of kidney. The kidney is par- renal involvement by lymphoma can look sim-
tially or totally replaced by tumor. The kid- ilar to renal cell carcinoma, metastasis, pyelo-
neys are usually enlarged, with decreased re- nephritis, focal abscess, or transitional cell
nal function not uncommon (Figs 28, 29). carcinoma (Fig 34). Primary lymphoma of the
4. Infiltration by contiguous retroperito- kidney is rare due to the lack of lymphoid tis-
neal disease. The kidney is directly invaded or sue within the kidney.
engulfed by adjacent tumor or enlarged
nodes. In cases with massive adenopathy, the
renal outline may be lost or poorly defined.
33. 34.
Figures 30-34. (30) Histiocytic lymphoma in a 68-year-old man. CT scan shows enlarged lymph nodes
infiltrating the right kidney as well as perirenal and pararenal spaces on the right side. (31) Lymphocytic-
histiocytic nodular lymphoma in a 74-year-old woman. CT scan reveals extensive paraaortic adenopathy di-
rectly invading the left kidney. Left hydronephrosis is also seen. (32) Histiocytic lymphoma in a 56-year-old
man. (a) CT scan demonstrates the left kidney replaced by tumor and extensive paraaortic nodes. The kid-
ney was nonfunctioning. (b) CT scan obtained 1 year after therapy demonstrates near resolution of tumor.
The left kidney is atrophic. (33) Diffuse histiocytic large cell lymphoma in a 59-year-old man. Extensive ade-
nopathy is seen, infiltrating pararenal and perirenal space bilaterally. Tumor involves the kidney by direct
extension. (34) Small cleaved cell follicular lymphoma in a 75-year-old man. CT scan shows tumor infiltrating
the right renal pelvis and kidney. Decreased renal function was noted. Tumor appearance is similar to that of
transitional cell carcinoma.
r.
;,‘: : I
I
.
*, I
36.
Figures 35-37. (35) B cell lymphoma (primary
adrenal tumor) in a 92-year-old man with a history
of abdominal pain. CT scan demonstrates bilateral
adrenal masses without evidence of adenopathy.
The diagnosis was made at percutaneous biopsy.
(36) Biopsy-proved large cell lymphoma in a 53-
year-old woman with a mass above the orbit. CT
scan demonstrates bilateral triangular adrenal
masses. An incidental splenic lesion is also seen.
(37) Diffuse histiocytic lymphoma in a 55-year-old
woman. CT scan demonstrates diffuse infiltration
of both adrenal glands by tumor. Extensive
paraaortic nodes are also seen.
37.
41.
48.
phoma (Fig 48). The prevalence of non- guishable from that oflymphoma in the im-
Hodgkin lymphoma is 35 times greater in pa- munocompetent patient (60-62). However,
tients with renal transplants than in the gen- posttransplantation lymphomas involve extra-
eral population. De novo malignancies affect nodal sites more frequently, especially the
6% of renal transplant recipients (59). Non- central nervous system. In patients with renal
Hodgkin lymphoma accounts for more than transplants, the transplant itself was the organ
20% of transplant-related malignancies. The most often infiltrated by tumor.
CT appearance of non-Hodgkin lymphoma in
the immunocompromised host is indistin-
V. .
. .,.‘. . .1
. ., . .
.;.
. .-‘“
4
.
. \.‘ .
#{149}
, .
k-’ . .-. ‘
54-